Latest Private Placement News

Dotz Nano appoints experienced tech leader Nati Harpaz as CEO amid a A$3.3 million capital raise, with Harpaz personally investing over A$1 million to back the company’s commercial push.

Laramide Resources posted a CAD 1.13 million net loss for Q1 2026, reflecting ongoing exploration costs and a one-off loss from exiting its Kazakhstan asset. The company’s mineral property base expanded to CAD 118.7 million, driven by Australian and US projects.

Novo Resources narrowed its Q1 2026 net loss to CAD 685K, boosted cash to CAD 10.6M following a $5.9M placement, and outlined aggressive gold and antimony drilling campaigns in Australia.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

Yowie Group’s June quarter reveals a revenue decline to $1.93 million, offset by improved operating cash inflows and a successful $516,000 capital raise. The company advances product launches in North America and Australia while undergoing significant board restructuring.

Spenda Limited has sold its Ledger platform to APG Pay for $1.8 million, cutting $2.7 million in annual costs and streamlining operations to concentrate on its core revenue-generating products.

Janus Electric has raised A$4.5 million through a discounted private placement, aiming to accelerate battery supply, truck production, and certification efforts across Australia and North America.

CDC Data Centres has landed Australia's largest-ever data centre contract, a 555MW deal with a US investment grade client that pushes its total contracted capacity beyond 1GW and is set to boost EBITDAF past A$1 billion in FY28.

Vicinity Centres delivered a resilient 3Q FY26 with high occupancy, strong retail sales growth, and a $654 million capital raise through long-dated debt issuances, reaffirming its FY26 earnings guidance at the top end.

Vicinity Centres delivered a robust third quarter in FY26 with high occupancy and retail sales growth, while successfully extending debt maturity and advancing key developments at Chatswood Chase and Galleria.

NeuRizer Ltd advanced its urea project with Reliance Industries payments and environmental submissions, despite ongoing ASX trading suspension and overdue financial reports.

AdAlta has secured A$2.5 million in a strategic placement to push its lead CAR-T therapy BZDS1901 through critical US FDA regulatory steps and establish Australian manufacturing, building on promising clinical responses in advanced mesothelioma.